Skip to content
Review Open access

Vitamin D status and breast cancer prevalence among US women: a descriptive cross‑sectional analysis of NHANES 2001‑2018

Sep 2026 · BMC Public Health · 0 citations

Abstract

Studies have reported an inverse association between vitamin D and breast cancer risk. However, most prior research has used prospective designs with vitamin D measured before diagnosis, leaving limited descriptive data on vitamin D status among women with prevalent breast cancers in the general US population. This study describes the association between vitamin D status and prevalent breast cancer using a large, nationally representative sample. We conducted a descriptive cross-sectional analysis of data from 15,904 women aged ≥ 20 years in the National Health and Nutrition Examination Survey (NHANES) 2001–2018. Breast cancer status was derived from the Medical Conditions Questionnaire (self-reported). Serum 25-hydroxyvitamin D [25(OH)D] was categorized as deficient (< 50 nmol/L), insufficient (50–74 nmol/L), or sufficient (≥ 75 nmol/L). Survey-weighted logistic regression was used to estimate unadjusted and sequentially adjusted associations. The weighted prevalence of breast cancer was 2.9%. Overall, 24.1% of women were vitamin D deficient, with markedly higher prevalence among non-Hispanic Black women (58.0%). In unadjusted analyses, sufficient vitamin D was associated with higher odds of prevalent breast cancer compared to deficiency (OR 2.48, 95% CI 1.78–3.46). This association was attenuated and no longer statistically significant after adjustment for age, race, season, education, hypertension, and diabetes (OR 1.27, 95% CI 0.89–1.81). Similar patterns were observed in subgroup analyses. These findings suggest no independent association between vitamin D status and prevalent breast cancers after adjustment for available covariates. However, residual confounding and the cross-sectional design with post-diagnosis vitamin D measurement preclude causal inference. Improving vitamin D deficiency remains important for bone health, but routine screening for breast cancer prevention is not supported by these data. Not applicable.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.